{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:38:43Z","timestamp":1759991923754},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T00:00:00Z","timestamp":1207094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s10096-008-0492-8","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T14:27:40Z","timestamp":1207060060000},"page":"685-690","source":"Crossref","is-referenced-by-count":11,"title":["Experimental study of meropenem in the therapy of cephalosporin-susceptible and -resistant pneumococcal meningitis"],"prefix":"10.1007","volume":"27","author":[{"given":"E.","family":"Force","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Taberner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cabellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F.","family":"Viladrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,2]]},"reference":[{"key":"492_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/34.1.175","volume":"34","author":"R Dagan","year":"1994","unstructured":"Dagan R, Velghe L, Rodda JL, Klugman KP (1994) Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrobial Chemother 34:175\u2013179","journal-title":"J Antimicrobial Chemother"},{"issue":"Suppl A","key":"492_CR2","first-page":"85","volume":"36","author":"E Schmutzhard","year":"1995","unstructured":"Schmutzhard E, Williams KJ, Vukmirovits G, Chemlik V, Pfausler B, Featherstone A (1995) A randomize comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group J Antimicrobial. Chemother 36(Suppl A):85\u201397","journal-title":"Chemother"},{"key":"492_CR3","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/AAC.39.5.1140","volume":"39","author":"KP Klugman","year":"1995","unstructured":"Klugman KP, Dagan R, Meropenem Study Group (1995) Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother 39:1140\u20131146","journal-title":"Antimicrob Agents Chemother"},{"key":"492_CR4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00006454-199907000-00004","volume":"18","author":"CM Odio","year":"1999","unstructured":"Odio CM, Puig JR, Feris JM, Khan WN, Rodriguez WJ, McCracken GH, Bradley JD (1999) Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children Meropenem Study Group. Pediatr Infect Dis J 18:581\u2013590","journal-title":"Pediatr Infect Dis J"},{"key":"492_CR5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267\u20131284","journal-title":"Clin Infect Dis"},{"key":"492_CR6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1128\/AAC.42.4.942","volume":"42","author":"F Fitoussi","year":"1998","unstructured":"Fitoussi F, Doit C, Benali K, Boacorsi S, Gelsin P, Bingen E (1998) Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin resistant Streptococcus pneumoniae isolates from children with meningitis. Antimicrob Agents Chemother 42:942\u2013944","journal-title":"Antimicrob Agents Chemother"},{"key":"492_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/45.1.5","volume":"45","author":"SR Norrby","year":"2000","unstructured":"Norrby SR (2000) Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis. J Antimicrobial Chemother 45:5\u20137","journal-title":"J Antimicrobial Chemother"},{"key":"492_CR8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s100960050421","volume":"18","author":"CM Gerber","year":"1999","unstructured":"Gerber CM, Cottagnoud M, Neftel KA, T\u00e4uber MG, Cottagnoud P (1999) Meropenem alone and in combination with vancomicin in experimental meningitis caused by a penicillin-resistant pneumoccocal strain. Eur J Clin Microbiol Infect Dis 18:886\u2013870","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"492_CR9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.37.8.1630","volume":"37","author":"IR Friedland","year":"1993","unstructured":"Friedland IR, Paris M, Ehrett S, Hickey S, Olsen K, McCracken JR (1993) Evaluation of antimicrobial regimens for treatment of experimental penicillin and cephalosporin resistant pneumococcal meningitis. Antimicrob Agents Chemother 37:1630\u20131636","journal-title":"Antimicrob Agents Chemother"},{"key":"492_CR10","doi-asserted-by":"crossref","unstructured":"Fukasawa M, Sumita Y, Harabe ET, Tanio T, Nouda H, Kohzuki et al (1992) Stability of meropenem and effect of 1\u03b2-methil substitution on its stability in the presence of renal dehydropeptidase I. J Antimicrobial Chemother 36:1577\u20131579","DOI":"10.1128\/AAC.36.7.1577"},{"issue":"Suppl A","key":"492_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/36.suppl_A.73","volume":"36","author":"K Nairn","year":"1995","unstructured":"Nairn K, Shepherd GL, Edwards JR (1995) Efficacy of meropenem in experimental meningitis. J Antimicrobial Chemother 36(Suppl A):73\u201384","journal-title":"J Antimicrobial Chemother"},{"key":"492_CR12","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically-(2000) 5th edn: Approved Standard M7-A5 NCCLS, Wayne, PA"},{"key":"492_CR13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.micinf.2006.12.013","volume":"9","author":"JM Maiques","year":"2007","unstructured":"Maiques JM, Domenech A, Cabellos C, Fern\u00e1ndez A, Ribes S, Tubau F et al (2007) Evaluation of antimicrobial regimens in a guinea-pig model of meningitis caused by Pseudomonas aeruginosa. Microb Infect 9:435\u2013441","journal-title":"Microb Infect"},{"key":"492_CR14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.6.4.437","volume":"6","author":"RG Dacey","year":"1974","unstructured":"Dacey RG, Sande MA (1974) Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother 6:437\u201341","journal-title":"Antimicrob Agents Chemother"},{"key":"492_CR15","first-page":"295","volume-title":"Antibiotics in laboratory medicine","author":"K Chapin-Robertson","year":"1991","unstructured":"Chapin-Robertson K, Edberg SC (1991) Measurements of antibiotics in human body fluids: techniques and significance. In: Lorian V (ed) Antibiotics in laboratory medicine. Williams and Wilkins, New York, pp 295\u2013366"},{"key":"492_CR16","doi-asserted-by":"crossref","unstructured":"Cottagnoud P, Cottagnoud M, Acosta F, Flatz L, K\u00fchn, Stucki A, Entenza J (2003) Meropenem prevents levofloxacin induced resistance in penicillin resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis. Eur J Clin Microbiol Infect Dis 22:656\u2013662","DOI":"10.1007\/s10096-003-1016-1"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-008-0492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-008-0492-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-008-0492-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:34:09Z","timestamp":1559122449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-008-0492-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,2]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1007\/s10096-008-0492-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,2]]}}}